Zhi Yao Selected Research

Zhi Yao Research Topics

Disease

85	Neoplasms (Cancer) 05/2024 - 11/2003
34	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2003
24	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2007
19	Inflammation (Inflammations) 12/2023 - 09/2006
17	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 04/2004
16	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 06/2003
12	Infections 03/2024 - 03/2005
10	Lung Neoplasms (Lung Cancer) 11/2018 - 09/2005
8	Carcinogenesis 01/2022 - 05/2011
8	Hypothyroidism 05/2021 - 01/2015
8	Carcinoma (Carcinomatosis) 11/2012 - 01/2006
7	Melanoma (Melanoma, Malignant) 04/2024 - 01/2006
7	Insulin Resistance 12/2020 - 12/2007
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 03/2013
6	Ovarian Neoplasms (Ovarian Cancer) 08/2023 - 07/2009
6	Fibrosis (Cirrhosis) 01/2020 - 10/2008
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 01/2016
6	Multiple Sclerosis 01/2019 - 03/2013
5	Parkinson Disease (Parkinson's Disease) 11/2022 - 03/2009
5	Hypoxia (Hypoxemia) 01/2020 - 12/2011
5	Leukemia 06/2017 - 04/2007
5	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 03/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 07/2014
4	Body Weight (Weight, Body) 12/2020 - 02/2004
4	Liver Neoplasms (Liver Cancer) 01/2018 - 11/2008
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 09/2009
4	Ovarian Epithelial Carcinoma 06/2009 - 10/2005
3	Cytomegalovirus Infections (Inclusion Disease) 01/2024 - 08/2006
3	Colitis 11/2023 - 01/2022
3	Necrosis 01/2023 - 10/2005
3	Wounds and Injuries (Trauma) 11/2022 - 01/2017
3	Experimental Melanoma 01/2021 - 04/2007
3	Thyroiditis 09/2020 - 01/2017
3	Obesity 01/2020 - 12/2011
2	Urinary Tract Infections (Urinary Tract Infection) 03/2024 - 01/2018
2	Bone Resorption 03/2024 - 04/2007
2	Fatigue 01/2024 - 07/2008

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2003
11	CytokinesIBA 01/2024 - 02/2004
11	Messenger RNA (mRNA)IBA 11/2018 - 06/2004
10	Therapeutic UsesIBA 01/2022 - 01/2006
10	tripeptide tyroservatideIBA 01/2016 - 01/2006
9	CateninsIBA 01/2020 - 02/2012
9	H-Tyr-Ser-Leu-OHIBA 01/2018 - 10/2005
8	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 12/2007
8	Interleukin-6 (Interleukin 6)IBA 01/2020 - 02/2004
8	Peptides (Polypeptides)IBA 01/2016 - 07/2008
7	LigandsIBA 04/2024 - 11/2003
7	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2010
6	Interleukin-17 (Interleukin 17)IBA 05/2020 - 11/2009
6	Conditioned Culture MediaIBA 01/2018 - 09/2005
5	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2021 - 06/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
5	Small Interfering RNA (siRNA)IBA 12/2020 - 03/2012
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2004
5	Long Noncoding RNAIBA 01/2020 - 07/2016
5	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2010
5	ChemokinesIBA 07/2016 - 06/2007
5	Interleukin-8 (Interleukin 8)IBA 09/2015 - 10/2005
5	Phosphatidylethanolamine Binding ProteinIBA 07/2009 - 06/2003
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2022
4	Dopamine (Intropin)FDA LinkGeneric 05/2023 - 01/2012
4	CalciumIBA 11/2022 - 10/2005
4	HomocysteineIBA 05/2021 - 01/2015
4	Estrogens (Estrogen)FDA Link 12/2015 - 10/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 11/2003
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2014 - 09/2006
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2009 - 09/2005
3	EnzymesIBA 04/2024 - 07/2008
3	Caspase 3 (Caspase-3)IBA 01/2024 - 12/2013
3	Dextran SulfateIBA 11/2023 - 01/2022
3	Indicators and Reagents (Reagents)IBA 11/2023 - 06/2011
3	CollagenIBA 08/2023 - 09/2013
3	Adenosine (Adenocard)FDA LinkGeneric 03/2022 - 01/2022
3	Amino Acids FDA Link 01/2022 - 01/2006
3	Phosphotransferases (Kinase)IBA 01/2021 - 02/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020 - 01/2015
3	AntibodiesIBA 09/2020 - 06/2017
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 11/2014
3	cytotoxic necrotizing factor type 1IBA 01/2020 - 10/2017
3	Protein Isoforms (Isoforms)IBA 11/2018 - 07/2013
3	Cadherins (E-Cadherin)IBA 01/2017 - 03/2011
3	AdiponectinIBA 01/2017 - 07/2014
3	Interleukin-4 (Interleukin 4)IBA 12/2015 - 02/2011
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2014 - 06/2003
3	Histones (Histone)IBA 01/2011 - 03/2006
3	RANK LigandIBA 04/2007 - 11/2003
3	Prostate-Specific Antigen (Semenogelase)IBA 03/2006 - 11/2003
2	GlucocorticoidsIBA 03/2024 - 01/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 01/2019
2	Hematoxylin (Haematoxylon)IBA 01/2024 - 01/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2023 - 01/2020

Therapy/Procedure

19	Therapeutics 01/2023 - 01/2006
8	Immunotherapy 05/2024 - 11/2011
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2008
5	Liver Transplantation 01/2024 - 08/2006
3	Radiotherapy 01/2020 - 07/2015
3	Intraperitoneal Injections 11/2008 - 02/2004
2	Electrodes (Electrode) 01/2024 - 01/2022